ERK activation and expression of neuronal cell cycle markers in the hippocampus after entorhinal cortex lesion

Journal of Neuroscience Research

Volumn 90, Issue 11, 2012, Pages 2116-2126

  Hernández Ortega, Karina ^a   Arias, Clorinda ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cell cycle; Dentate gyrus; Entorhinal cortex; ERK1 2; Excitotoxic damage; Neurodegeneration; Synaptic loss

Indexed keywords

CYCLIN B; CYCLIN D1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEURON SPECIFIC NUCLEAR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN NERVE CELL; CELL CYCLE PROGRESSION; CONTROLLED STUDY; DEAFFERENTATION; DENTATE GYRUS; DENTATE HILUS; ENTORHINAL CORTEX; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXCITOTOXICITY; HIPPOCAMPUS; IMMUNOREACTIVITY; INTRACELLULAR SIGNALING; MALE; MITOSIS; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BLOTTING, WESTERN; CELL CYCLE; ENTORHINAL CORTEX; ENZYME ACTIVATION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NERVE DEGENERATION; NEURONS; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84866033607     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23106     Document Type: Article

References (77)

1. Almeida RD, Manadas BJ, Melo CV, Gomes JR, Mendes CS, Grãos MM, Carvalho RF, Carvalho AP, Duarte CB. 2005. Neuroprotection by BDNF against glutamate-induced apoptotic cell death is mediated by ERK and PI3-kinase pathways. Cell Death Differ 12: 1329-1343.
2. Amaral DG, Insausti R, Cowan WM. 1987. The entorhinal cortex of the monkey: I. Cytoarchitectonic organization. J Comp Neurol 264: 326-355.
3. Arendt T. 2000. Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. Neurobiol Aging 21: 783-796.
4. Arendt T. 2001. Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. Neuroscience 102: 723-765.
5. Arendt T. 2005. Alzheimer's disease as a disorder of dynamic brain self-organization. Prog Brain Res 147: 355-378.
6. Arendt T, Brückner MK. 2007. Linking cell-cycle dysfunction in Alzheimer's disease to a failure of synaptic plasticity. Biochim Biophys Acta 1772: 413-421.
7. Arendt T, Holzer M, Grossmann A, Zedlick D, Brückner MK. 1995. Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience 68: 5-18.
8. Bechmann I, Nitsch R. 2000. Involvement of non-neuronal cells in entorhinal-hippocampal reorganization following lesions. Ann N Y Acad Sci 911: 192-206.
9. Bhaskar K, Miller M, Chludzinski A, Herrup K, Zagorski M, Lamb BT. 2009. The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events. Mol Neurodegener 4: 14-31.
10. Bonda DJ, Evans TA, Santocanale C, Llosá JC, Viña J, Bajic VP, Castellani RJ, Siedlak SL, Perry G, Smith MA, Lee HG. 2009. Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease. Aging 1: 382-388.
11. Braak H, Braak E. 1991. Neuropathological stageing of Alzheimer related changes. Acta Neuropathol 82: 239-259.
12. Braak H, Braak E. 1995. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 16: 271-288.
13. Busser J, Geldmacher DS, Herrup K. 1998. Ectopic cell cycle proteins predict the sites of neuronal death in Alzheimer's disease brain. J Neurosci 18: 2801-2807.
14. Butch ER, Guan K-L. 1996. Characterization of ERK1 activation site mutants and the effect on recognition by MEK1 and MEK2. J Biol Chem 271: 4230-4235.
15. Byrnes KR, Faden AI. 2007. Role of cell cycle proteins in CNS injury. Neurochem Res 32: 1799-1807.
16. Chao LL, Mueller SG, Buckley ST, Peek K, Raptentsetseng S, Elman J, Yaffe K, Miller BL, Kramer JH, Madison C, Mungas D, Schuff N, Weiner MW. 2010. Evidence of neurodegeneration in brains of older adults who do not yet fulfill MCI criteria. Neurobiol Aging 3: 368-377.
17. Copani A, Condorelli F, Caruso A, Vancheri C, Sala A, Giuffrida Stella AM, Canonico PL, Nicoletti F, Sortino MA. 1999. Mitotic signaling by β-amyloid causes neuronal death. FASEB J 13: 2225-2234.
18. Copani A, Caraci F, Hoozemans JJ, Calafiore M, Sortino MA, Nicoletti F. 2007. The nature of the cell cycle in neurons: focus on a "noncanonical" pathway of DNA replication causally related to death. Biochim Biophys Acta 1772: 409-412.
19. Dekosky ST, Scheff SW, Styren SD. 1996. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5: 417-721.
20. Deller T, Nitsch R, Frotscher M. 1996. Layer-specific sprouting of commissural fibres to the rat fascia dentata after unilateral entorhinal cortex lesion: a Phaseolus vulgaris leucoagglutinin tracing study. Neuroscience 71: 651-660.
21. Deller T, Del Turco D, Rappert A, Bechmann I. 2007. Structural reorganization of the dentate gyrus following entorhinal denervation: species differences between rat and mouse. Prog Brain Res 163: 501-528.
22. deToledo-Morrell L, Stoub TR, Bulgakova M, Wilson RS, Bennett DA, Leurgans S, Wuu J, Turner DA. 2004. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD. Neurobiol Aging 9: 1197-1203.
23. Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ. 2007. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 68: 828-836.
24. Dolorfo CL, Amaral DG. 1998. Entorhinal cortex of the rat: organization of intrinsic connections. J Comp Neurol 398: 49-82.
25. Drewes G, Lichtenberg-Kraag B, Döring F, Mandelkow EM, Biernat J, Goris J, Dorée M, Mandelkow E. 1992. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J 11: 2131-2138.
26. Fagan AM, Gage FH. 1994. Mechanisms of sprouting in the adult central nervous system: cellular responses in areas of terminal degeneration and reinnervation in the rat hippocampus. Neuroscience 58: 705-725.
27. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273: 18623-18632.
28. Ferrer I, Blanco R, Carmona M, Ribera R, Goutan E, Puig B, Rey MJ, Cardozo A, Viñals F, Ribalta T. 2001. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Brain Pathol 11: 144-158.
29. Gama Sosa MA, Wen PH, De Gasperi R, Perez GM, Senturk E, Friedrich VLJr, Elder GA. 2004. Entorhinal cortex lesioning promotes neurogenesis in the hippocampus of adult mice. Neuroscience 127: 881-91.
30. Gärtner U, Holzer M, Heumann R, Arendt T. 1995. Induction of p21ras in Alzheimer pathology. Neuroreport 6: 1441-1444.
31. Gärtner U, Holzer M, Arendt T. 1999. Elevated expression of p21 ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration. Neuroscience 91: 1-5.
32. Gärtner U, Brückner MK, Krug S, Schmetsdorf S, Staufenbiel M, Arendt T. 2003. Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons. Acta Neuropathol 106: 535-544.
33. Germroth P, Schwerdtfeger WK, Buhl EH. 1989. Morphology of identified entorhinal neurons projecting to the hippocampus. A light microscopical study combining retrograde tracing and intracellular injection. Neuroscience 30: 683-691.
34. Ginsberg SD, Galvin JE, Lee VM, Rorke LB, Dickson DW, Wolfe JH, Jones MZ, Trojanowski JQ. 1999. Accumulation of intracellular amyloid-beta peptide (A beta 1-40) in mucopolysaccharidosis brains. Neuropathol Exp Neurol 58: 815-824.
35. Giovanni A, Wirtz-Brugger F, Keramaris E, Slack R, Park DS. 1999. Involment of cell cycle element, cyclin D1ependent kinases, pRb and E2FxDP, in β-amyloid induced neuronal death. J Biol Chem 274: 19011-19016.
36. Goedert M, Cohen ES, Jakes R, Cohen P. 1992. p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease. FEBS Lett 312: 95-99.
37. Gómez-Isla T, Price JL, Mckeel DW, Morris JC, Grodwdon JH, Hyman BT. 2007. Profound loss of layer II entorhional cortex neurons ocurrs in very mild Alzheimer's disease. J Neurosci Res 85:1744-1751.
38. Hayashi T, Sakai K, Sasaki C, Zhang WR, Abe K. 2000. Phosphorylation of retinoblastoma protein in rat brain after transient middle cerebral artery occlusion. Neuropathol Appl Neurobiol 26: 390-397.
39. Hernández-Ortega K, Ferrera P, Arias C. 2007. Sequential expression of cell-regulators and Alzheimer's disease-related proteins in entorhinal cortex after hippocampal excitotoxic damage. J Neurosci Res 85: 1744-1751.
40. Herrup K, Busser JC. 1995. The induction of multiple cell cycle events precedes target-related neuronal death. Development 121: 2385-2395.
41. Hidalgo C, Núñez MT. 2007. Calcium, iron and neuronal function. IUBMB Life 59: 280-285.
42. Impey S, Obrietan K, Storm D. 1999. Making new connections: role of ERK/MAP kinase signalling in neuroplasticity. Neuron 23: 11-14.
43. Jaffee BD, Manos EJ, Collins RJ, Czerniak PM, Favata MF, Magolda RL, Scherle PA, Trzaskos JM. 2000. Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo. Biochem Biophys Res Commun 268: 647-651.
44. Jiang Q, Gu Z, Zhang G, Jing G. 2000. Diphosphorylation and involvement of extracellular signal-regulated kinases (ERK1/2) in glutamate-induced apoptotic-like death in cultured rat cortical neurons. Brain Res 857: 71-77.
45. Jordan-Sciutto KL, Dorsey R, Chalovich EM, Hammond RR, Achim CL. 2003. Expression patterns of retinoblastoma protein in Parkinson disease. J Neuropathol Exp Neurol 62: 68-74.
46. Kuroki Y, Fukushima K, Kanda Y, Mizuno K, Watanabe Y. 2001. Neuroprotection by estrogen via extracellular signal regulated kinase against quinolinic acid-induced cell death in the rat hippocampus. Eur J Neurosci 13: 472-476.
47. Lavoie J, L'Allemain G, Brunet A, Müller R, Pouysségur J. 1996. Cyclin D1 expression is regulated positively by the p44/p42 MAPKs and negatively by the p38/HOGMAPK pathway. J Biol Chem 271: 20608-20616.
48. Luo Y, DeFranco DB. 2006. Opposing roles for ERK 1/2 in neuronal oxidative toxicity: distinct mechanisms of ERK 1/2 action at early vs. late phases of oxidative stress. J Biol Chem 281: 16436-16442.
49. McShea A, Zelasko DA, Gerst JL, Smith MA. 1999. Signal transduction abnormalities in Alzheimer's disease: evidence of pathogenic stimuli. Brain Res 815: 237-242.
50. McShea A, Lee HG, Petersen RB, Casadesus G, Vincent I, Linford NJ, Funk JO, Shapiro RA, Smith MA. 2007. Neuronal cell cycle re-entry mediates Alzheimer disease-type changes. Biochim Biophys Acta 1772: 467-472.
51. Medina M-G, Ledesma MD, Domínguez JE, Medina M, Zafra D, Alameda A, Dotti CG, Navarro P. 2005. Tissue plasminogen activator mediates amyloid induced neurotoxicity via Erk1/2 activation. EMBO J 24: 1706-1716.
52. Mei M, Su B, Harrison K, Chao M, Siedlak SL, Previll LA, Jackson L, Cai DX, Zhu X. 2006. Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease. J Neurochem 99: 1377-1388.
53. Nagy Z, Esiri MM. 1998. Neuronal cyclin expression in the hippocampus in temporal lobe epilepsy. Exp Neurol 150: 240-247.
54. Nagy Z, Esiri MM, Cato AM, Smith AD. 1997. Cell cycle markers in the hippocampus in Alzheimer's disease. Acta Neuropathol 94: 6-15.
55. Park DS, Morris EJ, Padmanabban J, Shelanski ML, Geller HM, Greene LA. 1998. Cyclin D1-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J Cell Biol 143: 457-467.
56. Park KH, Hallows JL, Chakrabarty P, Davies P, Vincent I. 2007. Conditional neuronal simian virus 40 T antigen expression induces Alzheimer-like tau and amyloid pathology in mice. J Neurosci 27: 2969-2678.
57. Paxinos G, Watson C. 1998. The rat brain in stereotaxic coordinates. San Diego: Academic Press.
58. Payne DM, Rossomando AJ, Martino P, Erickson AK, Her JH, Shabanowitz J, Hunt DF, Weber MJ, Sturgill TW. 1991. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J 10: 885-892.
59. Pei JJ, Braak H, An WL, Winblad B, Cowburn RF, Iqbal K, Grundke-Iqbal I. 2002. Up-regulation of mitogen-activated protein kinases ERK 1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Brain Res Mol Brain Res 109: 45-55.
60. Perry G, Roder H, Nunomura A, Takeda A, Friedlich AL, Zhu X, Raina AK, Holbrook N, Siedlak SL, Harris PL, Smith MA. 1999. Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10: 2411-2415.
61. Price JL, Ko AI, Wade MJ, Tsou SK, McKeel DW, Morris JC. 2001. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol 58: 1395-1402.
62. Raina AK, Zhu X, Rottkamp CA, Monteiro M, Takeda A, Smith MA. 2000. Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. J Neurosci Res 61: 128-133.
63. Rangathan S, Bowser S. 2003. Alterations in G1 to S phase cell cycle regulators during amyotrophic lateral sclerosis. Am J Pathol 162: 823-835.
64. Scheff SW, Price DA. 2006. Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. J Alzheimers Dis 9: 101-115.
65. Schmetsdorf S, Arnold E, Holzer M, Arendt T, Gärtner U. 2009. A putative role for cell cycle-related proteins in microtubule-based neuroplasticity. Eur J Neurosci 29: 1096-1107.
66. Schmidt A, Kuhla B, Bigl K, Münch G, Arendt T. 2007. Cell cycle related signalling in Neuro2a cells proceeds via the receptor of advanced glycation end products. J Neural Transm 114: 1413-1424.
67. Stone SS, Teixeira CM, Devito LM, Zaslavsky K, Josselyn SA, Lozano AM, Frankland PW. 2011. Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory. J Neurosci 31: 13469-13484.
68. Stoub T, Barnes CA, Shah RC, Stebbins GT, Ferrari C, deToledo-Morrell L. 2011. Age-related changes in the mesial temporal lobe: the parahippocampal white matter region. Neurobiol Aging doi:10.1016/j.neurobiolaging.2011.02.010.
69. Subramaniam S, Unsicker K. 2010. ERK and cell death ERK 1/2 in neuronal death. FEBS J 277: 22-29.
70. Subramaniam S, Shahani N, Strelau J, Laliberté C, Brandt R, Kaplan D, Unsicker K. 2005. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway. J Neurosci 25: 2838-2852.
71. Sumrejkanchanakij P, Eto K, Ikeda M-A. 2006. Cytoplasmic sequestration of cyclin D1 associated with cell cycle withdrawal of neuroblastoma cells. Biochem Biophys Res Commun 340: 302-308.
72. Sutton GM, Duos B, Patterson LM, Berthoud H-R. 2005. Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus. Endocrinology 146: 3739-3747.
73. Sweatt JD. 2004. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 14: 311-17.
74. Verdaguer E, García-Jordà E, Canudas AM, Domínguez E, Jiménez A, Pubill D, Escubedo E, Pallàs JC, Camins A. 2002. Kainic acid- induced apoptosis in cerebellar granule neurons: an attempt at cell cycle re-entry. Neuroreport 13: 413-416.
75. Vincent I, Jicha G, Rosado M, Dickson D. 1997. Aberrant expression of mitotic Cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 17: 3588-3598.
76. Wiegert JS, Bading H. 2011. Activity-dependent calcium signaling and ERK-MAP kinases in neurons: a link to structural plasticity of the nucleus and gene transcription regulation. Cell Calcium 49: 296-305.
77. Yamamoto T, Ebisuya M, Ashida F, Okamoto K, Yonehara S, Nishida E. 2006. Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression. Curr Biol 16: 1171-1182.